KFGK
IBIO icon

Keystone Financial Group (Kentucky)’s iBio IBIO Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25
Closed -$13K – 289
2020
Q4 		$13K Sell
25
-2
-7% -$1.63K ﹤0.01% 262
2020
Q3 		$27K Buy
+27
New +$39.1K 0.01% 236

Other funds holding IBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s IBIO Position: Q1 2021 in Review

Keystone Financial Group (Kentucky) sold out of iBio (IBIO) in Q1 2021, closing a stake of 25 shares — an estimated $13K sold.

Keystone Financial Group (Kentucky) first reported a position in IBIO in Q3 2020 and held it in 2 quarters. The position peaked at $27K in Q3 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

  • Keystone Financial Group (Kentucky) reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
  • Keystone Financial Group (Kentucky) sold 25 iBio shares in Q1 2021, an estimated $13K.
  • Keystone Financial Group (Kentucky) first reported a position in iBio in Q3 2020 and held it in 2 quarters.
  • Keystone Financial Group (Kentucky)'s iBio position peaked at $27K in Q3 2020.
  • 91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2021, filed 11 May 2021.